1 line
16 KiB
Plaintext
1 line
16 KiB
Plaintext
{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T04:43:20Z","timestamp":1678769000874},"reference-count":29,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T00:00:00Z","timestamp":1678665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung, Basel Cardiovascular Research Foundation, and B Braun Medical AG"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCDD"],"abstract":"<jats:p>Background: We evaluated the outcome of PCI of de novo stenosis with drug-coated balloons (DCB) versus drug-eluting stents (DES) in patients with insulin-treated diabetes mellitus (ITDM) versus non-insulin-treated diabetes mellitus (NITDM). Methods: Patients were randomized in the BASKET-SMALL 2 trial to DCB or DES and followed over 3 years for MACE (cardiac death, non-fatal myocardial infarction [MI], and target vessel revascularization [TVR]). Outcome in the diabetic subgroup (n = 252) was analyzed with respect to ITDM or NITDM. Results: In NITDM patients (n = 157), rates of MACE (16.7% vs. 21.9%, hazard ratio [HR] 0.68, 95% confidence interval [CI] 0.29\u20131.58, p = 0.37), death, non-fatal MI, and TVR (8.4% vs. 14.5%, HR 0.30, 95% CI 0.09\u20131.03, p = 0.057) were similar between DCB and DES. In ITDM patients (n = 95), rates of MACE (DCB 23.4% vs. DES 22.7%, HR 1.12, 95% CI 0.46\u20132.74, p = 0.81), death, non-fatal MI, and TVR (10.1% vs. 15.7%, HR 0.64, 95% CI 0.18\u20132.27, p = 0.49) were similar between DCB and DES. TVR was significantly lower with DCB versus DES in all diabetic patients (HR 0.41, 95% CI 0.18\u20130.95, p = 0.038). Conclusions: DCB compared to DES for treatment of de novo coronary lesions in diabetic patients was associated with similar rates of MACE and numerically lower need for TVR both for ITDM and NITDM patients.<\/jats:p>","DOI":"10.3390\/jcdd10030119","type":"journal-article","created":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T08:04:00Z","timestamp":1678694640000},"page":"119","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Insulin-Treated Compared to Non-Insulin-Treated Diabetes Mellitus on Outcome of Percutaneous Coronary Intervention with Drug-Coated Balloons versus Drug-Eluting Stents in De Novo Coronary Artery Disease: The Randomized BASKET-SMALL 2 Trial"],"prefix":"10.3390","volume":"10","author":[{"given":"Julia","family":"Seeger","sequence":"first","affiliation":[{"name":"Medical Campus Lake Constance, Department of Cardiology and Intensive Care, 88048 Friedrichshafen, Germany"}]},{"ORCID":"http:\/\/orcid.org\/0000-0002-9915-1815","authenticated-orcid":false,"given":"Jochen","family":"W\u00f6hrle","sequence":"additional","affiliation":[{"name":"Medical Campus Lake Constance, Department of Cardiology and Intensive Care, 88048 Friedrichshafen, Germany"}]},{"given":"Bruno","family":"Scheller","sequence":"additional","affiliation":[{"name":"Clinical and Experimental Interventional Cardiology, University of Saarland, 66421 Homburg, Germany"}]},{"given":"Ahmed","family":"Farah","sequence":"additional","affiliation":[{"name":"Knappschaftskrankenhaus, Klinikum Westfalen, 44143 Dortmund, Germany"}]},{"given":"Marc-Alexander","family":"Ohlow","sequence":"additional","affiliation":[{"name":"SRH Wald-Klinikum Gera, 07548 Gera, Germany"}]},{"ORCID":"http:\/\/orcid.org\/0000-0003-0793-7923","authenticated-orcid":false,"given":"Norman","family":"Mangner","sequence":"additional","affiliation":[{"name":"Herzzentrum Dresden, Department of Internal Medicine and Cardiology, Technische Universit\u00e4t Dresden, 01062 Dresden, Germany"}]},{"given":"Sven","family":"M\u00f6bius-Winkler","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Hospital Jena, 07747 Jena, Germany"}]},{"given":"Daniel","family":"Weilenmann","sequence":"additional","affiliation":[{"name":"Cantonal Hospital St Gallen, 9007 St. Gallen, Switzerland"}]},{"given":"Georg","family":"Stachel","sequence":"additional","affiliation":[{"name":"Heart Center Leipzig, University Hospital, 04289 Leipzig, Germany"}]},{"given":"Gregor","family":"Leibundgut","sequence":"additional","affiliation":[{"name":"Cantonal Hospital Baselland, 4410 Liestal, Switzerland"}]},{"given":"Peter","family":"Rickenbacher","sequence":"additional","affiliation":[{"name":"University Hospital Basel, University of Basel, 4001 Basel, Switzerland"}]},{"ORCID":"http:\/\/orcid.org\/0000-0002-6610-8431","authenticated-orcid":false,"given":"Marco","family":"Cattaneo","sequence":"additional","affiliation":[{"name":"University Hospital Basel, University of Basel, 4001 Basel, Switzerland"}]},{"given":"Nicole","family":"Gilgen","sequence":"additional","affiliation":[{"name":"University Hospital Basel, University of Basel, 4001 Basel, Switzerland"}]},{"given":"Christoph","family":"Kaiser","sequence":"additional","affiliation":[{"name":"University Hospital Basel, University of Basel, 4001 Basel, Switzerland"}]},{"ORCID":"http:\/\/orcid.org\/0000-0003-1290-5491","authenticated-orcid":false,"given":"Raban","family":"Jeger","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Cardiovascular Research Institute Basel (CRIB), University Hospital Basel, 4031 Basel, Switzerland"},{"name":"Department of Cardiology, Triemli Hospital Zurich, 8063 Zurich, Switzerland"}]},{"name":"on behalf of the BASKET-SMALL 2 Investigators","sequence":"additional","affiliation":[]}],"member":"1968","published-online":{"date-parts":[[2023,3,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2011.08.007","article-title":"2011 ACCF\/AHA\/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions","volume":"58","author":"Levine","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/S0140-6736(20)32173-5","article-title":"Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial","volume":"396","author":"Jeger","year":"2020","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(18)31719-7","article-title":"Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): An open-label randomised non-inferiority trial","volume":"392","author":"Jeger","year":"2018","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1016\/j.jcin.2018.09.009","article-title":"Drug-Coated Balloon Versus Drug-Eluting Stent for Small-Vessel Disease: The RESTORE SVD China Randomized Trial","volume":"11","author":"Tang","year":"2018","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00392-014-0775-2","article-title":"Local paclitaxel induces late lumen enlargement in coronary arteries after balloon angioplasty","volume":"104","author":"Kleber","year":"2015","journal-title":"Clin. Res. Cardiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.carrev.2019.03.001","article-title":"Outcomes with Drug-Coated Balloons in Percutaneous Coronary Intervention in Diabetic Patients","volume":"21","author":"Megaly","year":"2020","journal-title":"Cardiovasc. Revasc. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0735-1097(02)01971-X","article-title":"Effects of coronary stenting on vessel patency and long-term clinical outcome after percutaneous coronary revascularization in diabetic patients","volume":"40","author":"Braune","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/j.jcin.2021.06.025","article-title":"Impact of Diabetes on Outcome with Drug-Coated Balloons Versus Drug-Eluting Stents: The BASKET-SMALL 2 Trial","volume":"14","author":"Scheller","year":"2021","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"5495219","DOI":"10.1155\/2021\/5495219","article-title":"Clinical Outcomes of Drug-Coated Balloon in Coronary Patients with and without Diabetes Mellitus: A Multicenter, Propensity Score Study","volume":"2021","author":"Pan","year":"2021","journal-title":"J. Diabetes Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jcin.2012.11.006","article-title":"Clinical outcome of patients with and without diabetes mellitus after percutaneous coronary intervention with the resolute zotarolimus-eluting stent: 2-year results from the prospectively pooled analysis of the international global RESOLUTE program","volume":"6","author":"Silber","year":"2013","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/ccd.28841","article-title":"Impact of insulin treated and non-insulin-treated diabetes compared to patients without diabetes on 1-year outcomes following contemporary PCI","volume":"96","author":"Chandrasekhar","year":"2020","journal-title":"Catheter Cardiovasc. Interv."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.amjcard.2018.02.034","article-title":"Outcomes in Patients with Diabetes Mellitus According to Insulin Treatment After Percutaneous Coronary Intervention in the Second-Generation Drug-Eluting Stent Era","volume":"121","author":"Pi","year":"2018","journal-title":"Am. J. Cardiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijcard.2016.10.032","article-title":"One year clinical outcomes in patients with insulin-treated diabetes mellitus and non-insulin-treated diabetes mellitus compared to non-diabetics after deployment of the bio-engineered COMBO stent","volume":"226","author":"Kalkman","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"ref_14","first-page":"15","article-title":"Long-term results after drug-eluting stent implantation in diabetic patients according to diabetic treatment","volume":"52","author":"Voudris","year":"2011","journal-title":"Hell. J. Cardiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/clc.22942","article-title":"Drug-coated balloons for de novo lesions in small coronary arteries: Rationale and design of BASKET-SMALL 2","volume":"41","author":"Gilgen","year":"2018","journal-title":"Clin. Cardiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.jcin.2020.02.043","article-title":"Drug-Coated Balloons for Coronary Artery Disease: Third Report of the International DCB Consensus Group","volume":"13","author":"Jeger","year":"2020","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.jacc.2012.08.001","article-title":"Third universal definition of myocardial infarction","volume":"60","author":"Thygesen","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: A case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0735-1097(98)00286-1","article-title":"The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation","volume":"32","author":"Abizaid","year":"1998","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12933-015-0300-6","article-title":"Adverse cardiovascular outcomes between insulin-treated and non-insulin treated diabetic patients after percutaneous coronary intervention: A systematic review and meta-analysis","volume":"14","author":"Bundhun","year":"2015","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.amjcard.2010.06.042","article-title":"Comparison of outcomes in patients with insulin-dependent versus non-insulin dependent diabetes mellitus receiving drug-eluting stents (from the first phase of the prospective multicenter German DES.DE registry)","volume":"106","author":"Akin","year":"2010","journal-title":"Am. J. Cardiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jacc.2014.06.1182","article-title":"Long-term outcome of PCI versus CABG in insulin and non-insulin-treated diabetic patients: Results from the FREEDOM trial","volume":"64","author":"Dangas","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.jcin.2015.04.008","article-title":"3-Year Follow-Up of the Balloon Elution and Late Loss Optimization Study (BELLO)","volume":"8","author":"Latib","year":"2015","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1016\/j.jcin.2020.08.035","article-title":"Drug-Coated Balloon Versus Drug-Eluting Stent for Small Coronary Vessel Disease: PICCOLETO II Randomized Clinical Trial","volume":"13","author":"Cortese","year":"2020","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"444","DOI":"10.4070\/kcj.2021.0261","article-title":"Clinical Results of Drug-Coated Balloon Treatment in a Large-Scale Multicenter Korean Registry Study","volume":"52","author":"Lee","year":"2022","journal-title":"Korean Circ. J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"131","DOI":"10.15420\/icr.2019.06.R3","article-title":"Drug-coated Balloons for Small Coronary Vessel Interventions: A Literature Review","volume":"14","author":"Nestelberger","year":"2019","journal-title":"Interv. Cardiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/joic.12333","article-title":"Drug-Coated Balloons: A Safe and Effective Alternative to Drug-Eluting Stents in Small Vessel Coronary Artery Disease","volume":"29","author":"Sinaga","year":"2016","journal-title":"J. Interv. Cardiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1056\/NEJM198705283162204","article-title":"Compensatory enlargement of human ath- erosclerotic coronary arteries","volume":"316","author":"Glagov","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.acvd.2017.01.005","article-title":"Contemporary use of drug-coated balloons in coronary artery disease: Where are we now?","volume":"110","author":"Picard","year":"2017","journal-title":"Arch. Cardiovasc. Dis."}],"container-title":["Journal of Cardiovascular Development and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2308-3425\/10\/3\/119\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T13:50:34Z","timestamp":1678715434000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2308-3425\/10\/3\/119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,13]]},"references-count":29,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["jcdd10030119"],"URL":"http:\/\/dx.doi.org\/10.3390\/jcdd10030119","relation":{},"ISSN":["2308-3425"],"issn-type":[{"value":"2308-3425","type":"electronic"}],"subject":["Pharmacology (medical)","General Pharmacology, Toxicology and Pharmaceutics"],"published":{"date-parts":[[2023,3,13]]}}} |